# SYMFI

NDC: 49502-475
Generic name: Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate
Labeler / Manufacturer: Viatris Specialty LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20180425

FDA application: NDA022142

## Active ingredients

- EFAVIRENZ: 600 mg/1
- LAMIVUDINE: 300 mg/1
- TENOFOVIR DISOPROXIL FUMARATE: 300 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"49502-475"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=49502-475
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=81a55dd9-78a8-49c3-88ab-8f5bffafa359